Nonbenzodiazepine sedative hypnotics and risk of fall-related injury

Sleep

Volumn 39, Issue 5, 2016, Pages 1009-1014

  Tom, Sarah E ^a   Wickwire, Emerson M ^b   Park, Yujin ^a   Albrecht, Jennifer S ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Hip fracture; Nonbenzodiazepine sedative hypnotics (NBSH); Traumatic brain injury

Indexed keywords

ESZOPICLONE; ZALEPLON; ZOLPIDEM; ACETAMIDE DERIVATIVE; HYPNOTIC SEDATIVE AGENT; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

AGED; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DRUG UTILIZATION; FALL RISK; FEMALE; FOLLOW UP; HIP FRACTURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRAUMATIC BRAIN INJURY; VERY ELDERLY; BRAIN INJURIES, TRAUMATIC; FALLING; HIP FRACTURES; ODDS RATIO; PREVENTION AND CONTROL; RISK ASSESSMENT; SLEEP INITIATION AND MAINTENANCE DISORDERS; STATISTICS AND NUMERICAL DATA;

ACCIDENTAL FALLS; ACETAMIDES; AGED; AGED, 80 AND OVER; BRAIN INJURIES, TRAUMATIC; CROSS-OVER STUDIES; ESZOPICLONE; FEMALE; HIP FRACTURES; HOSPITALIZATION; HUMANS; HYPNOTICS AND SEDATIVES; MALE; ODDS RATIO; PYRIDINES; PYRIMIDINES; RISK ASSESSMENT; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84965064095     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.5742     Document Type: Article

References (41)

1. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. an opportunity for prevention? JAMA 1989;262:1479-84.
2. Ganguli M, Reynolds CF, Gilby JE. Prevalence and persistence of sleep complaints in a rural older community sample: the MoVIES project. J Am Geriatr Soc 1996;44:778-84.
3. Ancoli-Israel S. Sleep and its disorders in aging populations. Sleep Med 2009;10 Suppl 1:S7-11.
4. Ford ES, Wheaton AG, Cunningham TJ, Giles WH, Chapman DP, Croft JB. Trends in outpatient visits for insomnia, sleep apnea, and prescriptions for sleep medications among US adults: findings from the national ambulatory medical care survey 1999-2010. Sleep 2014;37:1283-93.
5. Salva P, Costa J. Clinical pharmacokinetics and pharmacodynamics of zolpidem. therapeutic implications. Clin Pharmacokinet 1995;29:142-53.
6. Darcourt G, Pringuey D, Salliere D, Lavoisy J. The safety and tolerability of zolpidem - An update. J Psychopharmacol 1999;13:81-93.
7. Sauvanet JP, Langer SZ, Morselli PL, eds. Imidazopyridines in sleep disorders. New York, NY: Raven Press, 1988.
8. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012;60:616-31.
9. Lin FY, Chen PC, Liao CH, Hsieh YW, Sung FC. Retrospective population cohort study on hip fracture risk associated with zolpidem medication. Sleep 2014;37:673-9.
10. Kang DY, Park S, Rhee CW, et al. Zolpidem use and risk of fracture in elderly insomnia patients. J Prev Med Public Health 2012;45:219-26.
11. Chung SD, Lin CC, Wang LH, Lin HC, Kang JH. Zolpidem use and the risk of injury: a population-based follow-up study. PLoS One 2013;8:e67459.
12. Diem SJ, Ewing SK, Stone KL, et al. Use of non-benzodiazepine sedative hypnotics and risk of falls in older men. J Gerontol Geriatr Res 2014;3:158.
13. Finkle WD, Der JS, Greenland S, et al. Risk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults. J Am Geriatr Soc 2011;59:1883-90.
14. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Zolpidem use and hip fractures in older people. J Am Geriatr Soc 2001;49:1685-90.
15. Lai MM, Lin CC, Lin CC, Liu CS, Li TC, Kao CH. Long-term use of zolpidem increases the risk of major injury: a population-based cohort study. Mayo Clin Proc 2014;89:589-94.
16. Faul M, Xu L, Wald MM, Coronado VG. Traumatic brain injury in the United States: emergency department visits, hospitalizations and deaths 2002-2006. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control, 2010. Accessed 1/12/16. Available at: http://www.cdc.gov/traumaticbraininjury/pdf/blue-book.pdf.
17. Thurman DJ, National Center for Injury Prevention and Control. Guidelines for surveillance of central nervous system injury. Washington, DC: U.S. Department of Health and Human Services, Public Health Service, 1995.
18. Carroll CP, Cochran JA, Guse CE, Wang MC. Are we underestimating the burden of traumatic brain injury? Surveillance of severe traumatic brain injury using Centers for Disease Control International Classification of Disease, ninth revision, clinical modification, traumatic brain injury codes. Neurosurgery 2012;71:1064-70; discussion 1070.
19. Marr A, Coronado V, Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Central nervous system injury surveillance data submission standards. Washington, DC: U.S. Department of Health and Human Services, Public Health Service, 2004.
20. Centers for Medicare and Medicaid Services. Chronic condition data warehouse. Condition categories. Accessed 05/14/2015. Available from http://www.ccwdata.org/web/guest/condition-categories.
21. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991;133:144-53.
22. Maclure M, Mittleman MA. Should we use a case-crossover design? Annu Rev Public Health 2000;21:193-221.
23. Berry SD, Lee Y, Cai S, Dore DD. Nonbenzodiazepine sleep medication use and hip fractures in nursing home residents. JAMA Intern Med 2013;173:754-61.
24. Daley M, Morin CM, LeBlanc M, Gregoire JP, Savard J, Baillargeon L. Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents. Sleep Med 2009;10:427-38.
25. Mullington JM, Haack M, Toth M, Serrador JM, Meier-Ewert HK. Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Prog Cardiovasc Dis 2009;51:294-302.
26. Blackwell T, Yaffe K, Ancoli-Israel S, et al. Poor sleep is associated with impaired cognitive function in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci 2006;61:405-10.
27. Blackwell T, Yaffe K, Laffan A, et al. Associations of objectively and subjectively measured sleep quality with subsequent cognitive decline in older community-dwelling men: the MrOS sleep study. Sleep 2014;37:655-63.
28. Fortier-Brochu E, Beaulieu-Bonneau S, Ivers H, Morin CM. Insomnia and daytime cognitive performance: a meta-Analysis. Sleep Med Rev 2012;16:83-94.
29. Tariq SH, Pulisetty S. Pharmacotherapy for insomnia. Clin Geriatr Med 2008;24:93-105, vii.
30. Zint K, Haefeli WE, Glynn RJ, Mogun H, Avorn J, Sturmer T. Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults. Pharmacoepidemiol Drug Saf 2010;19:1248-55.
31. Frey DJ, Ortega JD, Wiseman C, Farley CT, Wright KP Jr. Influence of zolpidem and sleep inertia on balance and cognition during nighttime awakening: a randomized placebo-controlled trial. J Am Geriatr Soc 2011;59:73-81.
32. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008;4:487-504.
33. Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med 2004;164:1888-96.
34. Morin CM, Vallieres A, Guay B, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA 2009;301:2005-15.
35. Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 1999;281:991-9.
36. Sivertsen B, Omvik S, Pallesen S, et al. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA 2006;295:2851-8.
37. Botteman MF, Ozminkowski RJ, Wang S, Pashos CL, Schaefer K, Foley DJ. Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: a decision analytical model. CNS Drugs 2007;21:319-34.
38. Leger D, Bayon V, Ohayon MM, et al. Insomnia and accidents: crosssectional study (EQUINOX) on sleep-related home, work and car accidents in 5293 subjects with insomnia from 10 countries. J Sleep Res 2014;23:143-52.
39. Stone KL, Ancoli-Israel S, Blackwell T, et al. Actigraphy-measured sleep characteristics and risk of falls in older women. Arch Intern Med 2008;168:1768-75.
40. Stone KL, Blackwell TL, Ancoli-Israel S, et al. Sleep disturbances and risk of falls in older community-dwelling men: the outcomes of sleep disorders in older men (MrOS sleep) study. J Am Geriatr Soc 2014;62:299-305.
41. Avidan AY, Fries BE, James ML, Szafara KL, Wright GT, Chervin RD. Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes. J Am Geriatr Soc 2005;53:955-62.